Johan Grünewald

15.5k total citations · 3 hit papers
269 papers, 11.3k citations indexed

About

Johan Grünewald is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Johan Grünewald has authored 269 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Physiology, 150 papers in Pulmonary and Respiratory Medicine and 63 papers in Immunology. Recurrent topics in Johan Grünewald's work include Sarcoidosis and Beryllium Toxicity Research (129 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (121 papers) and Asthma and respiratory diseases (29 papers). Johan Grünewald is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (129 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (121 papers) and Asthma and respiratory diseases (29 papers). Johan Grünewald collaborates with scholars based in Sweden, United States and Germany. Johan Grünewald's co-authors include Anders Eklúnd, Hans Wigzell, Anders Eklund, Olle Olerup, Jan Wahlström, Lars Klareskog, Elizabeth V. Arkema, C. Magnus Sköld, Susanna Kullberg and Johan Askling and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Johan Grünewald

265 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination

2005 1.1k citations Lars Klareskog, Johan Grünewald et al. Arthritis & Rheumatism profile →
Sarcoidosis

2019 295 citations Johan Grünewald, Elizabeth V. Arkema et al. profile →
Challenges of Sarcoidosis and Its Management

2021 203 citations Johan Grünewald et al. profile →

Peers

Countries citing papers authored by Johan Grünewald

Since Specialization

Citations

This map shows the geographic impact of Johan Grünewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Grünewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Grünewald more than expected).

Fields of papers citing papers by Johan Grünewald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Grünewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Grünewald. The network helps show where Johan Grünewald may publish in the future.

Co-authorship network of co-authors of Johan Grünewald

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Grünewald. A scholar is included among the top collaborators of Johan Grünewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Grünewald. Johan Grünewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disease‐specific plasma protein profiles in patients with fever after traveling to tropical areas 2024 ·European Journal of Immunology ·Christopher Sundling, Victor Yman, Zaynab Mousavian, (unknown), (unknown), (unknown), (unknown), Johan Grünewald, Anna Färnert, Klara Sondén	1
2	CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope 2021 ·The Journal of Experimental Medicine ·(unknown), Avinash Ravindran, Radleigh G. Santos, Lan Chen, Michael T. Falta, Yang Wang, Angela M. Mitchell, Shaikh M. Atif, Douglas G. Mack, (unknown), Lisa A. Maier, Shaodong Dai, Clemencia Pinilla, Johan Grünewald, Andrew P. Fontenot	32
3	Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data 2021 ·Respirology ·Marios Rossides, Susanna Kullberg, Daniela Di Giuseppe, Anders Eklúnd, Johan Grünewald, Johan Askling, Elizabeth V. Arkema	24
4	Monocytes in sarcoidosis are potent tumour necrosis factor producers and predict disease outcome 2021 ·European Respiratory Journal ·Rico Lepzien, Sang Liu, Paulo Czarnewski, (unknown), Björn Österberg, Faezzah Baharom, Jamshid Pourazar, Gregory Rankin, Anders Eklúnd, Matteo Bottai, Susanna Kullberg, Anders Blomberg, Johan Grünewald, Anna Smed‐Sörensen	31
5	Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden 2021 ·Heart ·Marios Rossides, Susanna Kullberg, Johan Grünewald, Anders Eklúnd, Daniela Di Giuseppe, Johan Askling, Elizabeth V. Arkema	14
6	Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case–control study 2020 ·European Journal of Epidemiology ·Marios Rossides, Susanna Kullberg, Johan Askling, Anders Eklúnd, Johan Grünewald, Daniela Di Giuseppe, Elizabeth V. Arkema	12
7	Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study 2020 ·European Respiratory Journal ·Marios Rossides, Susanna Kullberg, Anders Eklúnd, Daniela Di Giuseppe, Johan Grünewald, Johan Askling, Elizabeth V. Arkema	29
8	Sarcoidosis diagnosis and treatment in Sweden: A register-based assessment of variations by region and calendar period 2019 ·Respiratory Medicine ·Marios Rossides, Susanna Kullberg, Anders Eklúnd, Johan Grünewald, Elizabeth V. Arkema	16
9	Proinflammatory Histidyl–Transfer RNA Synthetase–Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies 2019 ·Arthritis & Rheumatology ·Angeles S. Galindo‐Feria, Inka Albrecht, Cátia Fernandes‐Cerqueira, Antonella Notarnicola, Eddie A. James, Jessica Herrath, Maryam Dastmalchi, Tatyana Sandalova, Lars Rönnblom, Per‐Johan Jakobsson, Maryam Fathi, Adnane Achour, Johan Grünewald, Vivianne Malmström, Ingrid E. Lundberg	42
10	Familial aggregation and heritability of sarcoidosis: a Swedish nested case−control study 2018 ·European Respiratory Journal ·Marios Rossides, Johan Grünewald, Anders Eklúnd, Susanna Kullberg, Daniela Di Giuseppe, Johan Askling, Elizabeth V. Arkema	52
11	Sarcoidosis mortality in Sweden: a population-based cohort study 2018 ·European Respiratory Journal ·Marios Rossides, Susanna Kullberg, Johan Askling, Anders Eklúnd, Johan Grünewald, Elizabeth V. Arkema	63
12	Enhanced CD8+ cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-Löfgren's disease 2017 ·Respiratory Medicine ·Venkata Ramanarao Parasa, Helena Forsslund, (unknown), D. Lorenz, Susanna Kullberg, Anders Eklúnd, Magnus Sköld, Jan Wahlström, Johan Grünewald, Susanna Brighenti	20
13	Lipid mediator levels evidence gender-specific increases in bronchoalveolar lavage fluid of COPD patients relative to healthy smokers 2013 ·European Respiratory Journal ·Craig E. Wheelock, David Balgoma, Johan Grünewald, Anders Eklund, Magnus Sköld, Åsa M. Wheelock	1
14	Characterization Of Lung Inflammation and Identification Of Shared Citrullinated Targets In The Lungs and Joints Of Early RA 2013 ·Arthritis & Rheumatism ·Vijay Joshua, Gudrun Reynisdottir, (unknown), Marianne Engström, Anders Eklund, Magnus Sköld, Per‐Johan Jakobsson, Johan Rönnelid, Vivianne Malmström, Lars Klareskog, Johan Grünewald, Anca I. Catrina	4
15	HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis 2011 ·European Respiratory Journal ·Pernilla Darlington, Leif Tallstedt, Leonid Padyukov, Ingrid Kockum, Kerstin Cederlund, Anders Eklúnd, Johan Grünewald	49
16	Human Leukocyte Antigen Class I Alleles and the Disease Course in Sarcoidosis Patients 2003 ·American Journal of Respiratory and Critical Care Medicine ·Johan Grünewald, Anders Eklúnd, Olle Olerup	119
17	Organic dust-induced interleukin-12 production activates T- and natural killer cells 2002 ·European Respiratory Journal ·Charlotte Müller-Suur, Kjell Larsson, Johan Grünewald	12
18	Lung T-Helper Cells Expressing T-cell Receptor AV2S3 Associate with Clinical Features of Pulmonary Sarcoidosis 2000 ·American Journal of Respiratory and Critical Care Medicine ·Johan Grünewald, M Berlin, Olle Olerup, Anders Eklúnd	60
19	Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis 1997 ·European Respiratory Journal ·J. Wahlström, M Berlin, Rune Lundgren, Olle Olerup, Hans Wigzell, Anders Eklúnd, Johan Grünewald	43
20	Serum factors regulate 5-lipoxygenase activity in maturating HL60 cells 1993 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Dieter Steinhilber, Shigeru Hoshiko, Johan Grünewald, Olof Rådmark, Bengt Samuelsson	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact